The University of Kansas remains committed to building healthy communities by fostering innovation and economic prosperity. A step towards this strategic initiative is Startup School@KU.
September 21, 2016
A new type of licensing agreement now available to faculty members at the University of Kansas is making it easier for them to take lab discoveries and spin them out into new startup companies.
August 19, 2016
What elements support successful university-based commercialization? A look at how the process has evolved at five universities and what the implications are for business innovation.
July 6, 2016
BioNovus Innovations LLC and the University of Kansas Medical Center’s Institute for Advancing Medical Innovation (IAMI) announced a new partnership Tuesday to develop and commercialize new drugs, diagnostics and medical devices.
May 4, 2016
Demonstrating that a laboratory concept will work in practice is one key to moving a research discovery into the marketplace. The University of Kansas supports discovery and innovation in multiple ways, including the granting of Proof of Concept (POC) Fund awards for inventions that are near the commercialization stage.
May 3, 2016
Called KCRise, it's from a consortium of local economic development groups aiming to grow the amount of venture capital flowing into the City of Fountains.
April 14, 2016
Julie Nagel, the interim associate vice chancellor for innovation and entrepreneurship at the University of Kansas, has been named to the position permanently. In that role she serves as president of KU Innovation and Collaboration (KUIC), which manages intellectual property and technology commercialization at all KU campuses. She also provides leadership for the university’s overall economic development mission. The appointment is effective immediately.
April 14, 2016
At the University of Kansas, an innovative program gives faculty, staff and students the tools and knowledge they need to succeed as entrepreneurs. Best of all, they learn the ropes from people with experience, enthusiasm and a spirit of adventure.
April 12, 2016
A new drug to treat the muscle-wasting disease inclusion body myositis (IBM) reverses key symptoms in mice and is safe and well-tolerated in patients, finds a new study led by the Medical Research Council (MRC) Centre for Neuromuscular Diseases at UCL and the University of Kansas Medical Center.
March 28, 2016
The University of Kansas is entering into a new research collaboration that will position faculty and students to work with industry on technologies that enhance national security.
February 16, 2016